» Articles » PMID: 25889326

Neuroblastoma and Nephroblastoma: a Radiological Review

Overview
Journal Cancer Imaging
Publisher Springer Nature
Specialties Oncology
Radiology
Date 2015 Apr 19
PMID 25889326
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma (NBL) is the most common extra-cranial tumour in childhood. It can present as an abdominal mass, but is usually metastatic at diagnosis so the symptomatology can be varied. Nephroblastoma, also more commonly known as a Wilms tumour, is the commonest renal tumour in childhood and more typically presents as abdominal pathology with few constitutional symptoms, although rarely haematuria can be a presenting feature. The pathophysiology and clinical aspects of both tumours including associated risk factors and pathologies are discussed. Oncogenetics and chromosomal abnormalities are increasingly recognised as important prognostic indicators and their impact on initial management is considered. Imaging plays a pivotal role in terms of diagnosis and recent imaging advances mean that radiology has an increasingly crucial role in the management pathway. The use of image defined risk factors in neuroblastoma has begun to dramatically change how this tumour is characterised pre-operatively. The National Wilms Tumour Study Group have comprehensively staged Wilms tumours and this is reviewed as it impacts significantly on management. The use of contrast-enhanced MRI and diffusion-weighted sequences have further served to augment the information available to the clinical team during initial assessment of both neuroblastomas and Wilms tumours. The differences in management strategies are outlined. This paper therefore aims to provide a comprehensive update on these two common paediatric tumours with a particular emphasis on the current crucial role played by imaging.

Citing Articles

Metanephric stromal tumor as a rare differential diagnosis of a renal mass in children - a case report.

Riese R, Veldhoen S, Metz C, Scale C Pediatr Radiol. 2025; 55(2):352-355.

PMID: 39847094 PMC: 11805839. DOI: 10.1007/s00247-025-06166-w.


Advances in multimodal imaging for adrenal gland disorders: integrating CT, MRI, and nuclear medicine.

Yokoyama K, Matsuki M, Isozaki T, Ito K, Imokawa T, Ozawa A Jpn J Radiol. 2025; .

PMID: 39794659 DOI: 10.1007/s11604-025-01732-6.


Health-Related Quality of Life and Mental Health of Parents of Children with Pediatric Abdominal Tumors.

Zierke K, Boettcher M, Behrendt P, Najem S, Zapf H, Reinshagen K Children (Basel). 2024; 11(8).

PMID: 39201933 PMC: 11352779. DOI: 10.3390/children11080998.


Direct correlation of MR-DWI and histopathology of Wilms' tumours through a patient-specific 3D-printed cutting guide.

van der Beek J, Fitski M, de Krijger R, Vermeulen M, Nikkels P, Maat A Eur Radiol. 2024; 35(2):652-663.

PMID: 39115585 PMC: 11782413. DOI: 10.1007/s00330-024-10959-2.


Evaluation of clinical and imaging features for differentiating rhabdomyosarcoma from neuroblastoma in pediatric soft tissue.

Sheng J, Li T, Xu H, Xu R, Cai X, Zhang H Front Oncol. 2024; 14:1289532.

PMID: 38406807 PMC: 10884217. DOI: 10.3389/fonc.2024.1289532.


References
1.
Hiorns M, Owens C . Radiology of neuroblastoma in children. Eur Radiol. 2001; 11(10):2071-81. DOI: 10.1007/s003300100931. View

2.
Donnelly L, Frush D, Zheng J, Bisset 3rd G . Differentiating normal from abnormal inferior thoracic paravertebral soft tissues on chest radiography in children. AJR Am J Roentgenol. 2000; 175(2):477-83. DOI: 10.2214/ajr.175.2.1750477. View

3.
Lowe L, Isuani B, Heller R, Stein S, Johnson J, Navarro O . Pediatric renal masses: Wilms tumor and beyond. Radiographics. 2000; 20(6):1585-603. DOI: 10.1148/radiographics.20.6.g00nv051585. View

4.
Kembhavi S, Qureshi S, Vora T, Chinnaswamy G, Laskar S, Ramadwar M . Understanding the principles in management of Wilms' tumour: can imaging assist in patient selection?. Clin Radiol. 2013; 68(7):646-53. DOI: 10.1016/j.crad.2012.11.012. View

5.
McHugh K, Roebuck D . Pediatric oncology surveillance imaging: two recommendations. Abandon CT scanning, and randomize to imaging or solely clinical follow-up. Pediatr Blood Cancer. 2013; 61(1):3-6. DOI: 10.1002/pbc.24757. View